DRKS00010525已完成不适用
A prospective study on epidemiology and outcome of patients with traumatic brain injury (TBI) in BG-hospitals - ProSHT
BG Universitätsklinikum Bergmannsheil0 个研究点目标入组 3,524 人开始时间: 2016年5月17日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 3,524
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Epidemiological main project:
- •Patient with acute head injury, at least 18 years old, presentation at one of the participating hospitals within 24 hours afgter trauma and
- •1.At least one of the following symptoms:
- •-nausea/vomitting
- •-anterograde/retrograde amnesia
- •-impaired consciousness
- •-fracture of skull or face
- •-focal neurological sign
- •2. One of the following diagnosis:
- •- S02 Fracture of skull and facial bones
- •- S04 Injury of cranial nerves
- •- S06 Intracranial injury
- •- S07 Crushing injury of head
- •- S09 Other and unspecifed injuries of head
- •Subproject mild TBI:
- •Patient with mild TBI, defined by head injury and at least one of the following conditions:
- •-transient loss of consciousness <30min
- •-amnesia <24h
- •-transient qualitative or quantitative impairment of consciousness
- •-GCS 30 min after trauma between 13 and 15
排除标准
- •main project:
- •subproject:
- •-focal neurological sign
- •-intracranial bleeding or skull fracture as revealed by CCT
- •-relevant accompanying disorders
- •-history of neurological or psychiatric disorder
- •-contraindication for MRI
- •-insufficient knowledge of German language
研究者
相似试验
进行中（未招募）
不适用
Prospective Study of the Incidence and Outcome of Venoocclusive Disease (VOD) with the Prophylactic Use of Defibrotide (DF, Gentium, Italy) in Pediatric Stem Cell Transplantation - VOD-DF StudyHepatic veno-occlusive disease following hematopoietic stem cell transplantationEUCTR2004-000592-33-IEGentium S.p.A290
进行中（未招募）
1 期
Prospective Study of the Incidence and Outcome of Venoocclusive Disease (VOD) with the Prophylactic Use of Defibrotide (DF, Gentium, Italy) in Pediatric Stem Cell Transplantation - VOD-DF StudyHepatic veno-occlusive disease following hematopoietic stem cell transplantationMedDRA version: 9.1 Level: LLT Classification code 10047217 Term: Venoocclusive syndrome of the liverMedDRA version: 9.1 Level: LLT Classification code 10047207 Term: Veno-occlusive liver damageEUCTR2004-000592-33-GBGentium S.p.A270
进行中（未招募）
不适用
Prospective Study of the Incidence and Outcome of Venoocclusive Disease (VOD) with the Prophylactic Use of Defibrotide (DF, Gentium, Italy) in Pediatric Stem Cell Transplantation - VOD-DF StudyHepatic veno-occlusive disease following hematopoietic stem cell transplantationMedDRA version: 9.1Level: LLTClassification code 10047217Term: Venoocclusive syndrome of the liverMedDRA version: 9.1Level: LLTClassification code 10047207Term: Veno-occlusive liver damageEUCTR2004-000592-33-SEGentium S.p.A270
进行中（未招募）
不适用
Prospective Study of the Incidence and Outcome of Venoocclusive Disease (VOD) with the Prophylactic Use of Defibrotide (DF, Gentium, Italy) in Pediatric Stem Cell Transplantation - VOD-DF StudyHepatic veno-occlusive disease following hematopoietic stem cell transplantationMedDRA version: 9.1Level: LLTClassification code 10047217Term: Venoocclusive syndrome of the liverMedDRA version: 9.1Level: LLTClassification code 10047207Term: Veno-occlusive liver damageEUCTR2004-000592-33-CZGentium S.p.A270
进行中（未招募）
不适用
Prospective study of the incidence and outcome of Veno-occlusive disease (VOD)with the prophylactic use of Defibrotide (DF, Gentium, Italy) in pediatric stem cell transplantatioPrevention of hepatic veno-occlusive disease in pediatric patients at high risk of VODMedDRA version: 14.1Level: PTClassification code 10047216Term: Venoocclusive liver diseaseSystem Organ Class: 10019805 - Hepatobiliary disordersEUCTR2004-000592-33-ITGENTIUM360